论文部分内容阅读
目的分析咳嗽变异哮喘小儿患者采取孟鲁司特钠进行治疗的具体疗效。方法随机抽取120例小儿咳嗽变异性哮喘患者作为本组研究对象,按照随机双盲法将患者分为两组,平均各60例:对照组接受常规雾化吸入治疗,观察组联合使用孟鲁司特钠进行治疗。对比两组小儿患者的治疗效果。结果观察组患儿的咳嗽缓解时间以及咳嗽消失时间均明显短于对照组,组间差异具有统计学意义(P<0.05)。观察组本组治疗有效率为95%(57/60),对照组治疗有效率为80%(48/60),组间差异比较存在统计学意义(P<0.05)。结论小儿咳嗽变异性哮喘患者接受雾化吸入联合孟鲁司特钠疗效确切,极具临床应用价值。
Objective To analyze the curative effect of taking montelukast sodium in children with cough variant asthma. Methods A total of 120 children with cough variant asthma were randomly divided into two groups according to a randomized double-blind method: 60 cases in the control group received routine inhalation therapy, and 36 cases in the observation group were treated with montelukast Special sodium for treatment. The therapeutic effect of two groups of pediatric patients was compared. Results The cough remission time and cough disappearing time in the observation group were significantly shorter than those in the control group. The differences between the two groups were statistically significant (P <0.05). The effective rate of observation group was 95% (57/60) in the treatment group and 80% (48/60) in the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion Children with cough variant asthma receiving nebulized inhalation combined with montelukast sodium is effective and has great clinical value.